{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:40:21Z","timestamp":1786466421052,"version":"build-2736575974"},"reference-count":50,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,11]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Fetal and neonatal alloimmune thrombocytopenia (FNAIT) occurs when maternal anti\u2013fetal platelet antibodies, most frequently against human platelet antigen 1a (HPA-1a), cause fetal platelet destruction. The precise pathogenic mechanisms remain incompletely understood. Here, we examined potential mechanisms underlying anti\u2013HPA-1a\u2013mediated platelet clearance, focusing on phagocytosis, complement fixation, platelet activation, and desialylation. Anti\u2013HPA-1a antibodies in pooled plasma and in individual samples of 9 of 10 patients with FNAIT induced Fc gamma receptor (Fc\u03b3R)\u2013dependent platelet phagocytosis in vitro, indicating this as the major contributor to platelet destruction. In contrast, complement fixation, platelet activation (CD62P expression), and desialylation (Ricinus communis agglutinin I binding) were observed in only a minority of patients. To model anti\u2013HPA-1a\u2013mediated platelet clearance in vivo, we developed a dual-humanized mouse model combining HPA-1a\u2013expressing platelets (from APLDQ transgenic mice [C57BL\/6 mice expressing A30P32L33D39Q470 on a murine GPIIIa backbone]) with mice engineered to express human Fc\u03b3Rs in place of murine Fc\u03b3Rs. Platelets from APLDQ mice sensitized with anti\u2013HPA-1a sera underwent rapid clearance in these Fc\u03b3R-humanized recipients. Pretreatment with an Fc\u03b3RIII-blocking monovalent antibody significantly reduced clearance, confirming Fc\u03b3RIII\u2019s central role in mediating platelet destruction. These results demonstrate that Fc\u03b3RIII-dependent phagocytosis is a dominant mechanism in anti\u2013HPA-1a\u2013driven platelet clearance in this model. Although complement activation and platelet desialylation were observed in a minority of samples, their contribution to platelet destruction remains speculative. Together, these findings highlight the complexity of FNAIT pathophysiology yet identify Fc\u03b3RIII blockade as a promising strategy to prevent platelet clearance in this disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025019475","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:53:51Z","timestamp":1781117631000},"page":"5400-5410","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of human Fc\u03b3RIII prevents platelet destruction in a dual-humanized murine model of FNAIT"],"prefix":"10.1182","volume":"10","author":[{"given":"Zoya","family":"Tawhidi","sequence":"first","affiliation":[{"name":"1Centre for Innovation, Canadian Blood Services, Ottawa, ON, Canada"},{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5486-5542","authenticated-orcid":false,"given":"Ulrich J.","family":"Sachs","sequence":"additional","affiliation":[{"name":"4Institute for Clinical Immunology, Transfusion Medicine, and Haemostasis, Justus Liebig University, and Department of Thrombosis and Haemostasis, Giessen University Hospital, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3042-8919","authenticated-orcid":false,"given":"Lazaro","family":"Gil Gonzalez","sequence":"additional","affiliation":[{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, ON, Canada"},{"name":"5Toronto Platelet Immunobiology Group, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0322-0231","authenticated-orcid":false,"given":"Christopher J.","family":"Khoury","sequence":"additional","affiliation":[{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, ON, Canada"},{"name":"5Toronto Platelet Immunobiology Group, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2500-2876","authenticated-orcid":false,"given":"Yaima","family":"Tundidor","sequence":"additional","affiliation":[{"name":"1Centre for Innovation, Canadian Blood Services, Ottawa, ON, Canada"},{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, ON, Canada"},{"name":"5Toronto Platelet Immunobiology Group, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun Grace","family":"Wu","sequence":"additional","affiliation":[{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2350-1855","authenticated-orcid":false,"given":"Yoelys","family":"Cruz-Leal","sequence":"additional","affiliation":[{"name":"1Centre for Innovation, Canadian Blood Services, Ottawa, ON, Canada"},{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6838-2576","authenticated-orcid":false,"given":"Akash","family":"Gupta","sequence":"additional","affiliation":[{"name":"1Centre for Innovation, Canadian Blood Services, Ottawa, ON, Canada"},{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Shehata","sequence":"additional","affiliation":[{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"6Division of Hematology, Sinai Health System, Department of Medicine, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lani","family":"Lieberman","sequence":"additional","affiliation":[{"name":"1Centre for Innovation, Canadian Blood Services, Ottawa, ON, Canada"},{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"7Department of Clinical Pathology, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7621-2945","authenticated-orcid":false,"given":"Heyu","family":"Ni","sequence":"additional","affiliation":[{"name":"1Centre for Innovation, Canadian Blood Services, Ottawa, ON, Canada"},{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, ON, Canada"},{"name":"5Toronto Platelet Immunobiology Group, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5051-6916","authenticated-orcid":false,"given":"Alan H.","family":"Lazarus","sequence":"additional","affiliation":[{"name":"1Centre for Innovation, Canadian Blood Services, Ottawa, ON, Canada"},{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, ON, Canada"},{"name":"5Toronto Platelet Immunobiology Group, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"issue":"4","key":"2026081110261879100_bib1","first-page":"372","article-title":"Fetal and neonatal alloimmune thrombocytopenia","volume":"7","author":"Constantinescu","year":"2012","journal-title":"Maedica. (Bucur)"},{"key":"2026081110261879100_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/IJWH.S90753","article-title":"Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities","volume":"9","author":"Tiller","year":"2017","journal-title":"Int J Womens Health"},{"issue":"18","key":"2026081110261879100_bib3","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1182\/blood-2010-05-284919","article-title":"Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy","volume":"116","author":"Chen","year":"2010","journal-title":"Blood"},{"key":"2026081110261879100_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bpobgyn.2019.01.017","article-title":"Foetal and neonatal alloimmune thrombocytopenia","volume":"58","author":"Winkelhorst","year":"2019","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"2026081110261879100_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1479-828X.2010.01270.x","article-title":"A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry","volume":"51","author":"McQuilten","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2026081110261879100_bib6","doi-asserted-by":"crossref","first-page":"101038","DOI":"10.1016\/j.blre.2022.101038","article-title":"Fetal and neonatal alloimmune thrombocytopenia: current pathophysiological insights and perspectives for future diagnostics and treatment","volume":"59","author":"Stam","year":"2023","journal-title":"Blood Rev"},{"issue":"8","key":"2026081110261879100_bib7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nri856","article-title":"Roles of Fc receptors in autoimmunity","volume":"2","author":"Takai","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2026081110261879100_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-3148.1994.tb00240.x","article-title":"The expression of IgG Fc receptors on circulating leucocytes in the fetus and new-born","volume":"4","author":"Mawas","year":"1994","journal-title":"Transfus Med"},{"issue":"16","key":"2026081110261879100_bib9","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fc\u03b3 receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2026081110261879100_bib10","doi-asserted-by":"crossref","first-page":"102710","DOI":"10.1016\/j.transci.2019.102710","article-title":"The use of IVIg in fetal and neonatal alloimmune thrombocytopenia\u2014principles and mechanisms","volume":"59","author":"Wabnitz","year":"2020","journal-title":"Transfus. Apher. Sci"},{"issue":"7","key":"2026081110261879100_bib11","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2005-06-2562","article-title":"A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy","volume":"107","author":"Ni","year":"2006","journal-title":"Blood"},{"issue":"6","key":"2026081110261879100_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1034\/j.1600-0609.2000.065006399.x","article-title":"HPA-1a-mediated platelet interaction with monocytes in vitro: involvement of Fc\u03b3 receptor (Fc\u03b3R) classes and inhibition by humanised monoclonal anti-Fc\u03b3RI H22","volume":"65","author":"Wiener","year":"2000","journal-title":"Eur J Haematol"},{"key":"2026081110261879100_bib13","doi-asserted-by":"crossref","first-page":"1283704","DOI":"10.3389\/fimmu.2023.1283704","article-title":"In vitro analysis of anti-HPA-1a dependent platelet phagocytosis and its inhibition using a new whole blood phagocytosis assay (WHOPPA)","volume":"14","author":"Ames","year":"2023","journal-title":"Front Immunol"},{"issue":"13","key":"2026081110261879100_bib14","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.3390\/ijms22136763","article-title":"Placental complement activation in fetal and neonatal alloimmune thrombocytopenia: an observational study","volume":"22","author":"de Vos","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026081110261879100_bib15","first-page":"0236","article-title":"Desialylated platelet clearance in the liver is a novel mechanism of systemic immunosuppression","volume":"6","author":"Li","year":"2023","journal-title":"Research (Wash D C)"},{"key":"2026081110261879100_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.21037\/aob.2019.12.04","article-title":"Platelet physiology and immunology: pathogenesis and treatment of classical and non-classical fetal and neonatal alloimmune thrombocytopenia","volume":"4","author":"Chen","year":"2019","journal-title":"Ann Blood"},{"issue":"3","key":"2026081110261879100_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.0042-9007.2001.00105.x","article-title":"Human platelet antigen-1a antibodies induce the release of the chemokine RANTES from human platelets","volume":"81","author":"Dettke","year":"2001","journal-title":"Vox Sang"},{"issue":"1","key":"2026081110261879100_bib18","doi-asserted-by":"crossref","first-page":"102712","DOI":"10.1016\/j.transci.2019.102712","article-title":"Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia","volume":"59","author":"Kj\u00e6r","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"2026081110261879100_bib19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jtha.2022.11.041","article-title":"An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1\/2 proof-of-concept study","volume":"21","author":"Geisen","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2026081110261879100_bib20","doi-asserted-by":"crossref","first-page":"e0278365","DOI":"10.1371\/journal.pone.0278365","article-title":"THP-1 cells transduced with CD16A utilize Fc\u03b3 receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets","volume":"17","author":"Gil Gonzalez","year":"2022","journal-title":"PLoS One"},{"issue":"16","key":"2026081110261879100_bib21","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1073\/pnas.1203954109","article-title":"Mouse model recapitulating human Fc\u03b3 receptor structural and functional diversity","volume":"109","author":"Smith","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"2026081110261879100_bib22","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood.2022015666","article-title":"Prophylactic administration of HPA-1a\u2013specific antibodies prevents fetal\/neonatal alloimmune thrombocytopenia in mice","volume":"140","author":"Zhi","year":"2022","journal-title":"Blood"},{"issue":"8","key":"2026081110261879100_bib23","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/bloodadvances.2023012155","article-title":"Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP","volume":"8","author":"Gonzalez","year":"2024","journal-title":"Blood Adv"},{"issue":"26","key":"2026081110261879100_bib24","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood.2019003646","article-title":"Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP","volume":"135","author":"Khan","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2026081110261879100_bib25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3324\/haematol.2020.248385","article-title":"Fc\u03b3RI and Fc\u03b3RIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb\/IIIa autoantibody-opsonized platelets in immune thrombocytopenia","volume":"106","author":"Norris","year":"2021","journal-title":"Haematologica"},{"issue":"15","key":"2026081110261879100_bib26","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood.2020009497","article-title":"Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc\u03b3 receptor inhibition","volume":"137","author":"Norris","year":"2021","journal-title":"Blood"},{"issue":"2","key":"2026081110261879100_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0609.2011.01718.x","article-title":"Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)","volume":"88","author":"Najaoui","year":"2012","journal-title":"Eur J Haematol"},{"issue":"6","key":"2026081110261879100_bib28","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.V70.6.1722.1722","article-title":"Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies","volume":"70","author":"Kiefel","year":"1987","journal-title":"Blood"},{"key":"2026081110261879100_bib29","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3389\/fimmu.2020.01962","article-title":"Crosstalk between platelets and microbial pathogens","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"2026081110261879100_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1182\/blood-2008-03-145821","article-title":"Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression","volume":"114","author":"Yang","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2026081110261879100_bib31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/002215549804600508","article-title":"Lectin intravital perfusion studies in tumor-bearing mice: micrometer-resolution, wide-area mapping of microvascular labeling, distinguishing efficiently and inefficiently perfused microregions in the tumor","volume":"46","author":"Debbage","year":"1998","journal-title":"J Histochem Cytochem"},{"issue":"22","key":"2026081110261879100_bib32","doi-asserted-by":"crossref","first-page":"8943","DOI":"10.1073\/pnas.1014501108","article-title":"Deep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared window","volume":"108","author":"Welsher","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026081110261879100_bib33","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3389\/fimmu.2019.02415","article-title":"Low pH exposure during immunoglobulin G purification methods results in aggregates that avidly bind Fc\u03b3 receptors: implications for measuring Fc dependent antibody functions","volume":"10","author":"Lopez","year":"2019","journal-title":"Front Immunol"},{"issue":"9","key":"2026081110261879100_bib34","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3324\/haematol.2021.279751","article-title":"Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia","volume":"107","author":"Zheng","year":"2022","journal-title":"Haematologica"},{"issue":"1","key":"2026081110261879100_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-017-0413-3","article-title":"Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia","volume":"10","author":"Tao","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2026081110261879100_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40729-018-0134-6","article-title":"Direct activation of platelets by addition of CaCl2 leads coagulation of platelet-rich plasma","volume":"4","author":"Toyoda","year":"2018","journal-title":"Int J Implant Dent"},{"issue":"1","key":"2026081110261879100_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2007.08.001","article-title":"Fetal and neonatal alloimmune thrombocytopenia","volume":"22","author":"van den Akker","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5","key":"2026081110261879100_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/bjh.13639","article-title":"Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia","volume":"171","author":"Curtis","year":"2015","journal-title":"Br J Haematol"},{"key":"2026081110261879100_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.gendis.2015.02.003","article-title":"Platelets and platelet alloantigens: lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia","volume":"2","author":"Vadasz","year":"2015","journal-title":"Genes Dis"},{"key":"2026081110261879100_bib40","unstructured":"Rallybio\n          . Rallybio to discontinue development of RLYB212 for prevention of FNAIT. 8 April 2025. Accessed 20 April 2026. https:\/\/investors.rallybio.com\/news-releases\/news-release-details\/rallybio-discontinue-development-rlyb212-prevention-fnait\/."},{"issue":"1","key":"2026081110261879100_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/vox.12725","article-title":"Maternal HPA-1a antibody level and its role in predicting the severity of fetal\/neonatal alloimmune thrombocytopenia: a systematic review","volume":"114","author":"Kjaer","year":"2019","journal-title":"Vox Sang"},{"issue":"1","key":"2026081110261879100_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol Rev"},{"issue":"4","key":"2026081110261879100_bib43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","article-title":"A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy","volume":"123","author":"Kapur","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2026081110261879100_bib44","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/bjh.13648","article-title":"Classical complement pathway activation in immune thrombocytopenia purpura: inhibition by a novel C1s inhibitor","volume":"173","author":"Peerschke","year":"2016","journal-title":"Br J Haematol"},{"issue":"6","key":"2026081110261879100_bib45","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1182\/bloodadvances.2021006864","article-title":"Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia","volume":"7","author":"Broome","year":"2023","journal-title":"Blood Adv"},{"issue":"1","key":"2026081110261879100_bib46","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1038\/ncomms8737","article-title":"Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia","volume":"6","author":"Li","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"2026081110261879100_bib47","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3324\/haematol.2019.236117","article-title":"Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan","volume":"106","author":"Marini","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"2026081110261879100_bib48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13287-021-02189-w","article-title":"Fetal liver hematopoiesis: from development to delivery","volume":"12","author":"Lewis","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"22","key":"2026081110261879100_bib49","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1182\/blood.V114.22.2404.2404","article-title":"3G8 and GMA161, anti Fc\u03b3RIII inhibitory monoclonal antibodies in the treatment of chronic refractory ITP. (Summary of 2 pilot studies)","volume":"114","author":"Nakar","year":"2009","journal-title":"Blood"},{"issue":"30","key":"2026081110261879100_bib50","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J Biol Chem"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/15\/5400\/2536363\/blooda_adv-2025-019475-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/15\/5400\/2536363\/blooda_adv-2025-019475-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:43:48Z","timestamp":1786463028000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/15\/5400\/569082\/Inhibition-of-human-Fc-RIII-prevents-platelet"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":50,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026,8,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025019475","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8,11]]},"published":{"date-parts":[[2026,7,31]]}}}